© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Sydney Jennings
Articles
FDA Approves Next-Gen Noninvasive CRC Screening Test: Daily Dose
October 16, 2024
Your daily dose of the clinical news you may have missed.
GLP-1RAs May Lower Risk of Suicidal Ideation for Youth with Obesity, New Data Suggest
October 15, 2024
In a study of adolescents with obesity, those in the GLP-1RA group had a 33% lower risk of experiencing suicidal ideation or attempts compared with matched controls.
Depression, Anxiety in Youth with Chronic Pain: Daily Dose
October 15, 2024
Your daily dose of the clinical news you may have missed.
October Issue of Patient Care Online Supplement is Now Live
October 14, 2024
Find details on challenges primary care clinicians face in treating older adults with T2D and an expert discussion on navigating treatments to delay T1D.
Beer and Cider Associated with Higher Risk of Gout in Both Sexes vs Other Alcohol Types
October 14, 2024
Higher alcohol intake was associated with a greater risk of gout for both sexes, but the correlation was stronger in men than women, according to a recent study.
Effectiveness of Suicide Care Implementation in Primary Care: Daily Dose
October 14, 2024
Your daily dose of the clinical news you may have missed.
RSV Mortality Higher than for Influenza B After Hospital Discharge: Daily Dose
October 11, 2024
Your daily dose of the clinical news you may have missed.
Remdesivir Plus Dexamethasone Reduces Mortality Risk among Adults Hospitalized with COVID-19
October 10, 2024
Remdesivir plus dexamethasone was associated with reduced 14- and 28-day mortality vs dexamethasone alone, according to a large study of adults hospitalized with COVID-19.
Decrease in MHT Use over Past 2 Decades: Daily Dose
October 10, 2024
Your daily dose of the clinical news you may have missed.
COVID-19 Linked to Long-Term Risk of MACE, Especially Among Adults with non-O Blood Types
October 09, 2024
Prior SARS-CoV-2 infection was associated with a 2-fold increased risk for MACE for up to 3 years, even among people with no history of CVD, in a new analysis of UK Biobank data.